PLRX - PLIANT THERAPEUTICS, INC.
IEX Last Trade
13.7
-0.340 -2.482%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:34 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$14.04
-0.34
-2.42%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-03-09 | 2023-05-09 | 2023-08-09 | 2023-11-09 | 2024-02-27 | 2024-05-06 | |
| Total revenue | 4.989 M | 1.482 M | 1.965 M | 1.332 M | 248.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 4.989 M | 1.482 M | 1.965 M | 1.332 M | 248.000 K | 0.000 | 0.000 | 0.000 | |
| -70.29% | 32.59% | -32.21% | -81.38% | -100.00% | nan% | nan% | |||
| Operating expenses | 34.631 M | 33.429 M | 39.365 M | 43.427 M | 47.576 M | 47.685 M | 47.037 M | 52.392 M | |
| Selling general and admin | 8.296 M | 8.823 M | 14.251 M | 14.154 M | 14.574 M | 15.346 M | 13.854 M | 15.246 M | |
| Research and development | 26.335 M | 24.606 M | 25.114 M | 29.273 M | 33.002 M | 32.339 M | 33.183 M | 37.146 M | |
| Total expenses | 34.631 M | 33.429 M | 39.365 M | 43.427 M | 47.576 M | 47.685 M | 47.037 M | 52.392 M | |
| -3.47% | 17.76% | 10.32% | 9.55% | 0.23% | -1.36% | 11.38% | |||
| Operating income | -29.642 M | -31.947 M | -37.400 M | -42.095 M | -47.328 M | -47.685 M | -47.037 M | -52.392 M | |
| Ebit | -29.642 M | -31.947 M | -37.400 M | -42.095 M | -47.328 M | -47.685 M | -47.037 M | -52.392 M | |
| Pretax income | -29.546 M | -30.615 M | -35.060 M | -37.548 M | -41.192 M | -41.487 M | -41.109 M | -46.955 M | |
| 3.62% | 14.52% | 7.10% | 9.70% | 0.72% | -0.91% | 14.22% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -29.546 M | -30.615 M | -35.060 M | -37.548 M | -41.192 M | -41.487 M | -41.109 M | -46.955 M | |
| -3.62% | -14.52% | -7.10% | -9.70% | -0.72% | 0.91% | -14.22% | |||
| Net income | -29.546 M | -30.615 M | -35.060 M | -37.548 M | -41.192 M | -41.487 M | -41.109 M | -46.955 M | |
| -3.62% | -14.52% | -7.10% | -9.70% | -0.72% | 0.91% | -14.22% |